Health researchers working with DENT Neurologic Institute, Jamaica pharmaceutical company to increase global clinical research.

For all the ways Colorado’s cannabis industry has evolved over the decade-plus since legalization, one thing that remains ...

Aurora Cannabis with ticker ACB was trading in an ABC correction through 2024 after a sharp and impulsive rally at the beginning of 2024. It actually formed a nice bullish setup formation at the ...

In a report released today, Bill Kirk from Roth MKM reiterated a Hold rating on Aurora Cannabis (ACB – Research Report), with a price target of C$8.00. The company’s shares closed yesterday at ...

Bevo Plant Propagation Revenue: $8.9 million, a 22% increase year-over-year. Consumer Cannabis Revenue: $9.9 million, down from $11.6 million last year. Aurora Cannabis Inc (NASDAQ:ACB) reported a ...

Investing.com -- Shares of Aurora Cannabis (TSX:ACB) Inc. (NASDAQ: NASDAQ:ACB) (TSX: ACB) soared 40% following the announcement of its fiscal 2025 third-quarter results. The Edmonton-based company ...

a company involved in cannabis decontamination technology and control services, announced that through a partnership with Abstrax, a company involved in cannabis and terpene research, together created ...

February 5, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas, including cannabis stocks reports on trading for Aurora Cannabis Inc. (TSX: ACB ...

Aurora Cannabis Inc., a leading Canadian-based global medical cannabis company, has reported its financial and operational results for the third quarter of fiscal 2025, ending December 31, 2024. The ...